Oppenheimer cuts Albemarle target to $123, keeps outperform
Oppenheimer adjusted its outlook on Albemarle Corporation (NYSE:ALB), a global developer of lithium and other chemical solutions. The firm's analyst, Colin W. Rusch, reduced the price target to $123 ...